Thymidylate synthetase allelic imbalance in clear cell renal carcinoma-Reference-Cited by-同舟云学术

Thymidylate synthetase allelic imbalance in clear cell renal carcinoma

Published:2009-03-22 Issue:6 Volume:64 Page:1195-1200
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Colavito Davide,Cartei Giuseppe,Dal Bianco Massimo,Stecca Anna,Zustovich Fable,Dalle Carbonare Maurizio,Ragazzi Eugenio,Farina Miriam,Colombrino Eva,Leon Alberta

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-009-0986-9.pdf

Reference30 articles.

1. Garcia JA, Rini BI (2007) Recent progress in the management of advanced renal cell carcinoma. CA Cancer J Clin 57:112–125

2. Yagoda A, Abi-Rached B, Petrylak D (1995) Chemotherapy for advanced renal-cell carcinoma: 1983–1993. Semin Oncol 22:42–60

3. Bamias A, Deliveliotis Ch, Fountzilas G et al (2004) Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group. J Clin Oncol 22:2150–2154

4. Fizazi K, Rolland F, Chevreau C et al (2003) A phase II study of irinotecan in patients with advanced renal cell carcinoma. Cancer 98:61–65

5. Vis AN, van der Gaast A, van Rhijn BW et al (2002) A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy. Cancer Chemother Pharmacol 49:342–345

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis;2020-12-23

2. Establishment and Characterization of a New Intrahepatic Cholangiocarcinoma Cell Line Resistant to Gemcitabine;Cancers;2019-04-11

3. Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning;Molecular Oncology;2015-08-22

4. Anomalous altered expressions of downstream gene-targets in TP53-miRNA pathways in head and neck cancer;Scientific Reports;2014-09-04

5. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma;Carcinogenesis;2013-05-28